resveratrol has been researched along with Hypoxia-Ischemia, Brain in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 10 (55.56) | 24.3611 |
| 2020's | 5 (27.78) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, H; Le, K; Peng, J; Peng, X; Wang, J | 1 |
| Bouzier-Sore, AK; Goudeneche, P; Pellerin, L; Roumes, H | 1 |
| Guo, J; Li, H; Li, X; Liu, Z; Shi, R; Sun, Y; Wang, Y; Wu, S; Yin, H | 1 |
| Beauvieux, MC; Bouzier-Sore, AK; Chateil, JF; Deffieux, D; Dumont, U; Olivier, B; Pellerin, L; Quideau, S; Roumes, H; Sanchez, S | 1 |
| Aum, DJ; Clarke, JV; Diwan, D; Gidday, JM; Han, BH; Lawrence, M; Nelson, JW; Vellimana, AK; Zipfel, GJ | 1 |
| Bian, H; Chen, T; Shan, H | 1 |
| Feng, J; Fu, R; Gao, Y; Wang, J; Wen, L; Yang, X | 1 |
| Ali, AI; Chibaatar Daliv, E; Guo, Y; Le, K; Qian, F; Wu, S; Yu, D | 1 |
| Ferriero, DM; Juul, SE | 1 |
| Alvarez, A; Arteaga, O; Hilario, E; Martinez-Ibargüen, A; Montalvo, H; Revuelta, M | 1 |
| Chen, L; Li, H; Rao, Y; Wang, J; Wang, P | 1 |
| Álvarez, A; Arteaga, O; Hilario, E; Montalvo, H; Revuelta, M; Urigüen, L | 1 |
| Fang, M; Hu, Y; Jiang, H; Li, S; Li, Z; Lin, Z; Liu, Y; Pan, S; Xiao, J; Xu, K; Zhang, H | 1 |
| Cheng, G; Dong, W; Gao, D; Jiang, X; Zhang, X | 1 |
| Chen, H; Jiang, Y; Li, C; Li, H; Yan, Z; Yang, J; Zhang, Z | 1 |
| Georgiou, T; Guiba-Tziampiri, O; Karalis, F; Nakas, CT; Simeonidou, C; Soubasi, V; Spandou, E | 1 |
| Atzeva, M; Holtzman, DM; West, T | 1 |
| Kimelberg, HK; Lei, T; Schools, GP; Wang, W; Zhang, H; Zhou, M | 1 |
2 review(s) available for resveratrol and Hypoxia-Ischemia, Brain
| Article | Year |
|---|---|
Resveratrol and Some of Its Derivatives as Promising Prophylactic Treatments for Neonatal Hypoxia-Ischemia.
Topics: Animals; Animals, Newborn; Hypoxia-Ischemia, Brain; Ischemia; Neuroprotective Agents; Polyphenols; Resveratrol | 2022 |
Pharmacologic neuroprotective strategies in neonatal brain injury.
Topics: Acetylcysteine; Allopurinol; Antioxidants; Ascorbic Acid; Biopterins; Erythropoietin; Excitatory Amino Acid Antagonists; Free Radical Scavengers; Fructose; Humans; Hypoxia-Ischemia, Brain; Infant, Extremely Premature; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Melatonin; Memantine; Neuroprotective Agents; Nitric Oxide Synthase Type III; Resveratrol; Stilbenes; Topiramate; Vitamin E; Xenon | 2014 |
16 other study(ies) available for resveratrol and Hypoxia-Ischemia, Brain
| Article | Year |
|---|---|
Resveratrol Improves Synaptic Plasticity in Hypoxic-Ischemic Brain Injury in Neonatal Mice via Alleviating SIRT1/NF-κB Signaling-Mediated Neuroinflammation.
Topics: Animals; Animals, Newborn; Brain Injuries; Hypoxia-Ischemia, Brain; Mice; Neuroinflammatory Diseases; Neuronal Plasticity; NF-kappa B; Rats; Rats, Sprague-Dawley; Resveratrol; Sirtuin 1 | 2022 |
Resveratrol reserved hypoxia-ischemia induced childhood hippocampal dysfunction and neurogenesis via improving mitochondrial dynamics.
Topics: Animals; Animals, Newborn; Hippocampus; Hypoxia; Hypoxia-Ischemia, Brain; Ischemia; Maze Learning; Mice; Mitochondrial Dynamics; Neurogenesis; Resveratrol | 2020 |
Maternal alcoholism and neonatal hypoxia-ischemia: Neuroprotection by stilbenoid polyphenols.
Topics: Alcohol Drinking; Alcoholism; Animals; Animals, Newborn; Brain; Brain Injuries; Cognitive Dysfunction; Female; Hypoxia; Hypoxia-Ischemia, Brain; Ischemia; Male; Maternal Nutritional Physiological Phenomena; Maternal-Fetal Exchange; Neuroprotection; Neuroprotective Agents; Polyphenols; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2020 |
SIRT1 mediates hypoxic preconditioning induced attenuation of neurovascular dysfunction following subarachnoid hemorrhage.
Topics: Animals; Antioxidants; Carbazoles; Hypoxia-Ischemia, Brain; Ischemic Preconditioning; Male; Mice; Mice, Inbred C57BL; Resveratrol; Sirtuin 1; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2020 |
Resveratrol ameliorates hypoxia/ischemia-induced brain injury in the neonatal rat via the miR-96/Bax axis.
Topics: Animals; Animals, Newborn; bcl-2-Associated X Protein; Brain; Hypoxia-Ischemia, Brain; MicroRNAs; Neuroprotective Agents; PC12 Cells; Rats; Resveratrol; Stilbenes | 2017 |
Resveratrol mitigates the oxidative stress mediated by hypoxic-ischemic brain injury in neonatal rats via Nrf2/HO-1 pathway.
Topics: Animals; Antioxidants; Brain Edema; Cerebral Cortex; Cytokines; Heme Oxygenase-1; Hypoxia-Ischemia, Brain; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; Rats; Rats, Sprague-Dawley; Resveratrol | 2018 |
SIRT1-regulated HMGB1 release is partially involved in TLR4 signal transduction: A possible anti-neuroinflammatory mechanism of resveratrol in neonatal hypoxic-ischemic brain injury.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents; Brain; Cell Proliferation; Cell Survival; Cells, Cultured; Cytokines; Female; HMGB1 Protein; Hypoxia-Ischemia, Brain; Mice, Inbred ICR; Microglia; Neurons; Neuroprotective Agents; Resveratrol; Signal Transduction; Sirtuin 1; Toll-Like Receptor 4 | 2019 |
Antioxidant Treatments Recover the Alteration of Auditory-Evoked Potentials and Reduce Morphological Damage in the Inferior Colliculus after Perinatal Asphyxia in Rat.
Topics: Animals; Animals, Newborn; Antioxidants; Astrocytes; Body Weight; Disease Models, Animal; Docosahexaenoic Acids; Evoked Potentials, Auditory, Brain Stem; Gliosis; Hypoxia-Ischemia, Brain; Inferior Colliculi; Melatonin; Neurons; Neuroprotective Agents; Nicotine; Oligodendroglia; Organ Size; Random Allocation; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Stilbenes | 2016 |
Resveratrol Reverses the Synaptic Plasticity Deficits in a Chronic Cerebral Hypoperfusion Rat Model.
Topics: Animals; Carotid Stenosis; Cerebrovascular Circulation; Chronic Disease; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Dementia, Vascular; Dendritic Spines; Dentate Gyrus; Enzyme Activation; Hypoxia-Ischemia, Brain; Learning Disabilities; Long-Term Potentiation; Male; Maze Learning; Memory Disorders; Nerve Tissue Proteins; Neuroprotective Agents; Random Allocation; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2016 |
Pretreatment with Resveratrol Prevents Neuronal Injury and Cognitive Deficits Induced by Perinatal Hypoxia-Ischemia in Rats.
Topics: Animals; Animals, Newborn; Astrocytes; Behavior, Animal; Brain; Brain Injuries; Cognition Disorders; Disease Models, Animal; Female; Hypoxia-Ischemia, Brain; Male; Membrane Potential, Mitochondrial; Mitochondria; Myelin Basic Protein; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Stilbenes | 2015 |
Resveratrol post-treatment protects against neonatal brain injury after hypoxia-ischemia.
Topics: Animals; Animals, Newborn; bcl-2-Associated X Protein; Brain Injuries; Caspase 3; Cytokines; Disease Models, Animal; Gene Expression Regulation; Hypoxia-Ischemia, Brain; Male; Microglia; Neuroprotective Agents; Proto-Oncogene Proteins c-bcl-2; Rats; Resveratrol; Stilbenes | 2016 |
Resveratrol inhibits MMP-9 expression by up-regulating PPAR alpha expression in an oxygen glucose deprivation-exposed neuron model.
Topics: Animals; Antioxidants; Cells, Cultured; Enzyme Inhibitors; Hypoxia-Ischemia, Brain; Indoles; Lipoxygenase Inhibitors; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Neurons; PPAR alpha; Resveratrol; RNA, Messenger; Stilbenes; Up-Regulation | 2009 |
Neuroprotective effects of resveratrol on ischemic injury mediated by modulating the release of neurotransmitter and neuromodulator in rats.
Topics: Animals; Antioxidants; Brain; Brain Infarction; Disease Models, Animal; Ethanolamines; Excitatory Postsynaptic Potentials; Extracellular Fluid; gamma-Aminobutyric Acid; Glutamic Acid; Glycine; Hypothalamus; Hypoxia-Ischemia, Brain; Infarction, Middle Cerebral Artery; Inhibitory Postsynaptic Potentials; Male; Neuroprotective Agents; Neurotransmitter Agents; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Treatment Outcome | 2010 |
Resveratrol ameliorates hypoxia/ischemia-induced behavioral deficits and brain injury in the neonatal rat brain.
Topics: Animals; Animals, Newborn; Brain Injuries; Female; Hypoxia-Ischemia, Brain; Male; Maze Learning; Memory; Neuroprotective Agents; Rats; Rats, Wistar; Reflex, Righting; Resveratrol; Stilbenes | 2011 |
Pomegranate polyphenols and resveratrol protect the neonatal brain against hypoxic-ischemic injury.
Topics: Animals; Animals, Newborn; Antioxidants; Apoptosis; Birth Injuries; Calpain; Caspase 3; Caspase Inhibitors; Disease Models, Animal; Enzyme Activation; Female; Flavonoids; Hypoxia-Ischemia, Brain; Lythraceae; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Phenols; Plant Extracts; Polyphenols; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Treatment Outcome | 2007 |
Resveratrol attenuates early pyramidal neuron excitability impairment and death in acute rat hippocampal slices caused by oxygen-glucose deprivation.
Topics: Action Potentials; Animals; Antioxidants; Carbocyanines; Cell Death; Hippocampus; Hypoxia-Ischemia, Brain; Large-Conductance Calcium-Activated Potassium Channels; Membrane Potentials; Nerve Degeneration; Organ Culture Techniques; Potassium Channel Blockers; Pyramidal Cells; Rats; Resveratrol; Stilbenes; Time Factors | 2008 |